Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ease of Use and Tolerability of Norditropin NordiFlex® in Growth Hormone naïve Children: Impact on Daily Life

NCT01327924 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01327924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ease of Use and Tolerability of Norditropin NordiFlex® in Growth Hormone naïve Children: Impact on Daily Life
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
June 30, 2012
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, chronic renal insufficiency, delivery systems, foetal growth problem, genetic disorder, growth hormone deficiency in children, growth hormone disorder, small for gestational age, turner syndrome